Claudia Monaco, MD PhD, Professor of Cardiovascular Inflammation at the Kennedy Institute of Rheumatology, NDORMS and Hon. Consultant Cardiologist at the OUH NHS Trust is part of an international team that will seek to use immunotherapy to better treat atherosclerosis, the process of narrowing of the arteries that causes myocardial infarction and stroke.
The Leducq Foundation, which is dedicated to battling cardiovascular disease and stroke, has funded a total of four projects worldwide for 2022, and one of those, called CHECKPOINT ATHERO, involves researchers at Mayo Clinic USA, Radboud University Medical Center in Nijmegen in the Netherlands, University of Oxford, Lund University in Sweden, Leiden University and Geisel School of Medicine in USA, led by Esther Lutgens (Mayo) and Willem Mulder (Nijmegen).
Read the full story on the Kennedy Institute of Rheumatology website.